5.00

Dr Abdul Rahman El Kinge is a highly experienced Medical Oncologist at Fakeeh University Hospital, Dubai, certified by the European Society of Medical Oncology (ESMO), Saudi Commission for Health Specialties, Department of Health Abu Dhabi (HAAD), Ministry of Health and Prevention (MOH) and the Dubai Health Authority (DHA).

Dr El Kinge completed his medical degree at Beirut Arab University, Lebanon in 2002 followed by his residency in Internal Medicine at the American University of Beirut Medical Center, Lebanon in 2005. He later completed a postdoctoral fellowship in haematology and oncology at the American University of Beirut Medical Center in 2008. Dr El Kinge also did training in Breast Cancer at the prestigious MD Anderson Cancer Center in the United States.

Dr El Kinge has expertise in a wide range of cancer types and treatments. He excels in the treatment of early, advanced, and metastatic breast cancer, as well as the management and chemotherapy of gastrointestinal, lung, pancreatic, biliary, genitourinary cancers, lymphoma, and hematologic malignancies. Dr El Kinge is well-versed in the delivery of targeted, molecular, epigenetic, and immunotherapy, and possesses expertise in managing coagulation/bleeding disorders and cancer-related thrombosis. He also provides comprehensive management of anaemia, leukopenia and thrombocytopenia.

Dr El Kinge has special interests and expertise in precision medicine and artificial Intelligence in cancer care, reflecting his commitment to utilising cutting-edge technologies to improve patient outcomes. Outside of his clinical work, Dr El Kinge is actively involved in the academic and research community, serving on the editorial boards and as a reviewer for multiple international medical journals. He is also an Adjunct Clinical Assistant Professor at the University of Sharjah and Deputy Program Director of the Internal Medicine Residency Training Program at the Specialised Medical Center in Riyadh.

His dedication to advancing medical knowledge is evident through his numerous peer-reviewed publications. As a Fellow of the American College of Physicians and a member of local and international haematology and oncology societies, he remains connected to the latest developments in the field and fosters collaborations with other experts.